| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/19/2005 | EP1497412A2 Adenovirus vectors for immunotherapy |
| 01/19/2005 | EP1497411A1 Embryo modification and implantation |
| 01/19/2005 | EP1497408A2 Method for making a molecularly smooth surface |
| 01/19/2005 | EP1497334A2 Protein stabilisation using chaperone proteins |
| 01/19/2005 | EP1497333A2 Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi |
| 01/19/2005 | EP1497332A1 Bispecific antibody binding tcr and tirc7 and its use in therapy and diagnosis |
| 01/19/2005 | EP1497330A2 Antagonists of factor viii interaction with low-density lipoprotein receptor-related protein |
| 01/19/2005 | EP1497327A2 Method for the identification of inhibitors of the binding of are-containing mrna and an hur protein |
| 01/19/2005 | EP1497324A2 CD4 sp + /sp T-LYMPHOCYTE-SPECIFIC HEPATITIS C VIRUS EPITOPES |
| 01/19/2005 | EP1497319A2 Cell adhesion and extracellular matrix proteins |
| 01/19/2005 | EP1497315A2 Nucleic acid-associated proteins |
| 01/19/2005 | EP1497314A2 Compositions and methods of use of targeting peptides against placenta and adipose tissues |
| 01/19/2005 | EP1497312A2 Nucleic acid separation and detection by electrophoresis with a counter-migrating high-affinity intercalating dye |
| 01/19/2005 | EP1497307A2 Recombinant p.falciparum merozoite protein-1 42 vaccine |
| 01/19/2005 | EP1497306A1 Alternatively spliced nucleic acid molecules |
| 01/19/2005 | EP1497302A2 Polymer-coated substrates for immobilization of biomolecules and cells |
| 01/19/2005 | EP1496980A2 Compositions and methods for the acceleration of protein secretion dynamics |
| 01/19/2005 | EP1496979A2 Protamine-adenoviral vector complexes and methods of use |
| 01/19/2005 | EP1496944A2 Improved raav expression systems for genetic modification of specific capsid proteins |
| 01/19/2005 | EP1496943A2 Oligomeric compounds having modified phosphate groups |
| 01/19/2005 | EP1496939A2 Modified cea nucleic acid and expression vectors |
| 01/19/2005 | EP1496937A2 Dna vaccine combined with an inducer of tumor cell apoptosis |
| 01/19/2005 | EP1496935A2 Insulin and igf-1 receptor agonists and antagonists |
| 01/19/2005 | EP1496926A1 Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins |
| 01/19/2005 | EP1496925A2 Use of interleukin-24 to treat ovarian cancer |
| 01/19/2005 | EP1496886A1 Knockout mice and their use |
| 01/19/2005 | EP1496834A2 High affinity integrin polypeptides and uses thereof |
| 01/19/2005 | EP1496743A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/19/2005 | EP1496737A2 .ce1, a regulator of cold induced transcriptome and freezing tolerance in plants |
| 01/19/2005 | EP1463942A4 Methods for purifying protein |
| 01/19/2005 | EP1411762A4 Combinations of genes for producing seed plants exhibiting modulated reproductive development |
| 01/19/2005 | EP1404812A4 Dopaminergic neurons and proliferation-competent precursor cells for treating parkinson's disease |
| 01/19/2005 | EP1404708A4 Non-endogenous, constitutively activated versions of plant g protein-coupled receptor: gcr1 |
| 01/19/2005 | EP1392366A4 Nuclear receptor-mediated introduction of a pna into cell nuclei |
| 01/19/2005 | EP1390482A4 Compositions and methods for random nucleic acid mutagenisis |
| 01/19/2005 | EP1368501A4 Mutation detection using muts and reca |
| 01/19/2005 | EP1356281A4 Rapid and quantitative proteome analysis and related methods |
| 01/19/2005 | EP1320617A4 Genetic engineering of syringyl-enriched lignin in plants |
| 01/19/2005 | EP1319179A4 Methods for detecting and assaying nucleic acid sequences |
| 01/19/2005 | EP1282709A4 Method of modifying the content of cottonseed oil |
| 01/19/2005 | EP1232282B1 Automated method for identifying related biomolecular sequences |
| 01/19/2005 | EP1171638A4 Methods for identifying a protease inhibitor |
| 01/19/2005 | EP1070081A4 Novel molecules of the t129-related protein family and uses thereof |
| 01/19/2005 | EP1034298A4 Humanization of murine antibody |
| 01/19/2005 | EP0943158B1 Affinity based self-assembly systems and devices for photonic and electronic applications |
| 01/19/2005 | EP0918863B1 Frozen food product containing heat stable antifreeze protein |
| 01/19/2005 | EP0888461A4 Tissue remodeling proteins |
| 01/19/2005 | EP0833899B1 Cis-9,10-octadecenoamidase |
| 01/19/2005 | EP0821737A4 NUCLEOTIDE SEQUENCE OF THE HAEMOPHILUS INFLUENZAE Rd GENOME, FRAGMENTS THEREOF, AND USES THEREOF |
| 01/19/2005 | EP0706572B1 Microbial transformants of hansenula that express glycolate oxydase and catalase |
| 01/19/2005 | EP0680517B2 Methods and diagnostic kits utilizing mammalian stress promoters to determine toxicity of a compound |
| 01/19/2005 | CN1568427A Micro flow passage device, connection device, and method of using the devices |
| 01/19/2005 | CN1568425A Molecular diagnostic and computerized decision support system for selecting the optimum treatment for human cancer |
| 01/19/2005 | CN1568374A Method for identifying compounds modulating reverse cholesterol transport |
| 01/19/2005 | CN1568373A RNA interference mediating small rna molecules |
| 01/19/2005 | CN1568370A Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists |
| 01/19/2005 | CN1568369A Hybrid interferon/interferon Tau proteins, compositions and methods of use |
| 01/19/2005 | CN1568367A Method for unspecific enrichment of bacterial cells |
| 01/19/2005 | CN1568366A Methods for injecting avian eggs |
| 01/19/2005 | CN1568331A Biological products |
| 01/19/2005 | CN1568330A Glycosylphosphatidylinositol containing polypeptides |
| 01/19/2005 | CN1568222A Solid compositions for selective adsorption from complex mixtures |
| 01/19/2005 | CN1568197A Composite superimmunogen for bi-functional vaccine use for the treatment of illnesses associated with a stromal tissue disorder |
| 01/19/2005 | CN1568194A Modulation of smooth muscle cell proliferation |
| 01/19/2005 | CN1568141A TYRA gene and its application |
| 01/19/2005 | CN1566948A Method for measuring skin absorbability of a substance |
| 01/19/2005 | CN1566917A Process for preparing triticeae chromosome specimen |
| 01/19/2005 | CN1566355A Recombinase process for production of sialic acid |
| 01/19/2005 | CN1566348A G type non-viral vector and pharmaceutical composition containing same |
| 01/19/2005 | CN1566347A N type non-viral vector and pharmaceutical composition containing same |
| 01/19/2005 | CN1566346A Expression and separation purification for S-protein of recombinant SARS coronavirus |
| 01/19/2005 | CN1566345A Homologous sequence linked with yellow dwarf-resistant gene Bdv2 and use thereof |
| 01/19/2005 | CN1566344A cDNA sequence of gene GhRLK1 expressed specifically in cotton fibre and use thereof |
| 01/19/2005 | CN1566343A Method for making chitosan nanoparticle-pcDNA3.1-hVEGF gene complex |
| 01/19/2005 | CN1566342A Antigenic epitope of S-protein of SARS coronavirus, antibody of S-protein of SARS coronavirus , nucleic acid encoding S-protein of SARS coronavirus and compositions containing same |
| 01/19/2005 | CN1566341A In vitro molecular directed evolution method for reshaping antibody |
| 01/19/2005 | CN1566340A Edible mushroom distant protoplast fusion breeding method |
| 01/19/2005 | CN1566338A Unhairing protease and polynucleotide encoding same |
| 01/19/2005 | CN1566337A Method for producing phytase using transgenic plant |
| 01/19/2005 | CN1566159A Genet engineering recombinant protein capable of specifically killing tumor cell |
| 01/19/2005 | CN1566158A Recombinant vaccine for prevention and treatment of SARS virus |
| 01/19/2005 | CN1566157A Preparing method and use for osteoprotegerin fusion protein |
| 01/19/2005 | CN1566156A Recombinant target fusion protein GnRH-TNFam and its antitumor use |
| 01/19/2005 | CN1566155A Anti-SARS monoclonal antibody, encoding sequence and application thereof |
| 01/19/2005 | CN1566154A Novel hepatocyte growth factor, preparing process and application thereof |
| 01/19/2005 | CN1566150A Human amyloid precursor protein 639, coded sequence and uses thereof |
| 01/19/2005 | CN1566149A Immunosuppressive receptor derived from dendritic cell, coded sequence and uses thereof |
| 01/19/2005 | CN1566148A Tumor suppressor, coded protein and application thereof |
| 01/19/2005 | CN1566147A Transcription factor for regulating and controlling gibberellin generation, coded gene and application thereof |
| 01/19/2005 | CN1566146A Paddy rice stalk extension gene, coded protein and application thereof |
| 01/19/2005 | CN1566144A Functional protein in SARS coronavirus |
| 01/19/2005 | CN1566142A Polypeptide drug for inhibiting SARS coronavirus from infecting host cell |
| 01/19/2005 | CN1566134A Non-structural protein gene of coronavirus and use thereof |
| 01/19/2005 | CN1566133A Artificial traction fiber protein gene and cascade method and expression thereof |
| 01/19/2005 | CN1566132A Schizophrenia susceptible gene----KPNB3 gene and uses thereof |
| 01/19/2005 | CN1565650A Tissue vascularization promoting gene-chitosan nanometer granula complex |
| 01/19/2005 | CN1565628A Usage of reovirus genome and its coding protein in the SARS related research |
| 01/19/2005 | CN1565627A Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
| 01/19/2005 | CN1565621A Obtainment of cell growth inhibiting polypeptide and its usage |
| 01/19/2005 | CN1185492C Single-point strobed micro electromagnetic units array chip or electromagnetic biologic chip and application thereof |